STAAR Surgical Reports Fourth Quarter and Full Year 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
STAAR Surgical (STAA) Tops Q4 EPS by 5c, Revenues Beat
February 24, 2021 4:41 PM ESTSTAAR Surgical (NASDAQ: STAA) reported Q4 EPS of $0.07, $0.05 better than the analyst estimate of $0.02. Revenue for the quarter came in at $46 million versus the consensus estimate of $43.85 million.
Fourth Quarter 2020 Overview
Net Sales of $46.0 Million Up 18% from the Prior Year QuarterICL Sales of $39.8 Million Up 20% from the Prior Year QuarterICL Units Up 13% from the Prior Year... More